BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 26166587)

  • 41. Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303.
    Arzimanoglou A; Ferreira J; Satlin A; Olhaye O; Kumar D; Dhadda S; Bibbiani F
    Eur J Paediatr Neurol; 2019 Jan; 23(1):126-135. PubMed ID: 30309816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ
    Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
    [No Abstract]   [Full Text] [Related]  

  • 43. Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations.
    Cross JH; Auvin S; Falip M; Striano P; Arzimanoglou A
    Front Neurol; 2017; 8():505. PubMed ID: 29085326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The unchanging face of Lennox-Gastaut syndrome in adulthood.
    Reyhani A; Özkara Ç
    Epilepsy Res; 2021 May; 172():106575. PubMed ID: 33721709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review.
    Balagura G; Riva A; Marchese F; Verrotti A; Striano P
    Neuropsychiatr Dis Treat; 2020; 16():369-379. PubMed ID: 32103957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical options for patients with Lennox-Gastaut syndrome.
    Douglass LM; Salpekar J
    Epilepsia; 2014 Sep; 55 Suppl 4():21-8. PubMed ID: 25284034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical management of Lennox-Gastaut syndrome.
    Michoulas A; Farrell K
    CNS Drugs; 2010 May; 24(5):363-74. PubMed ID: 20158289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic approach to Lennox-Gastaut syndrome: a systematic review.
    Borrelli S; El Tahry R
    Acta Neurol Belg; 2019 Sep; 119(3):315-324. PubMed ID: 31286465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Short-term efficacy and safety of rufinamide for Lennox-Gastaut syndrome].
    Takayama R; Fukumura S; Minagawa K; Watanabe T
    No To Hattatsu; 2016 Sep; 48(5):322-6. PubMed ID: 30010275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infantile spasms and Lennox-Gastaut syndrome.
    Trevathan E
    J Child Neurol; 2002 Feb; 17 Suppl 2():2S9-2S22. PubMed ID: 11952036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta-Analysis.
    Lattanzi S; Brigo F; Cagnetti C; Trinka E; Silvestrini M
    CNS Drugs; 2018 Oct; 32(10):905-916. PubMed ID: 30132269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome.
    Zhang Y; Wang Y; Zhou Y; Zhang L; Yu L; Zhou S
    Epilepsy Res; 2016 Dec; 128():176-180. PubMed ID: 27846468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox-Gastaut syndrome: A prospective observational clinical study.
    Operto FF; Verrotti A; Marrelli A; Ciuffini R; Coppola G; Pastorino GMG; Striano P; Sole M; Zucca C; Manfredi V; Città S; Elia M
    Epilepsy Behav; 2020 Nov; 112():107445. PubMed ID: 32920379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation.
    Kossoff EH; Shields WD
    Epilepsia; 2014 Sep; 55 Suppl 4():29-33. PubMed ID: 25284035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nocturnal interictal epileptic discharges in adult Lennox-Gastaut syndrome: the effect of sleep stage and time of night.
    Sforza E; Mahdi R; Roche F; Maeder M; Foletti G
    Epileptic Disord; 2016 Mar; 18(1):44-50. PubMed ID: 26842220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy and tolerability of auto-stimulation-VNS in children with Lennox-Gastaut syndrome.
    Abdelmoity SA; Abdelmoity AA; Riordan SM; Kaufman C; Le Pichon JB; Abdelmoity A
    Seizure; 2021 Mar; 86():168-174. PubMed ID: 33626436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome.
    Grosso S; Coppola G; Cusmai R; Parisi P; Spalice A; Foligno S; Verrotti A; Balestri P
    Acta Neurol Scand; 2014 Jun; 129(6):420-4. PubMed ID: 24479878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy).
    Kluger G; Bauer B
    Neuropsychiatr Dis Treat; 2007 Feb; 3(1):3-11. PubMed ID: 19300535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epilepsy Surgery is a Viable Treatment for Lennox Gastaut Syndrome.
    Keator CG
    Semin Pediatr Neurol; 2021 Jul; 38():100894. PubMed ID: 34183143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
    Isojarvi J; Gidal BE; Chung S; Wechsler RT
    Epilepsy Behav; 2018 Jan; 78():149-154. PubMed ID: 29202277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.